Phoenix, Arizona — Qiagen N.V. showcased its strong performance in the life sciences tools sector during the Evercore 8th Annual Healthcare Conference, held on December 3, 2025. The event featured key executives from Qiagen, including Chief Financial Officer Roland Sackers, alongside John Gilardi, Vice President of Corporate Communications, and Daniel Wendorff, Vice President of Investor Relations.

During the conference, the discussion was anchored around Qiagen’s impressive organic growth, highlighting its resilience amid a challenging economic climate. Vijay Kumar, an analyst with Evercore ISI, posed pivotal questions about the company’s strategy and market positioning. Notably, he pointed out that despite difficulties faced by the sector, Qiagen’s performance outshone its peers, particularly in relationships with government entities and academia.

Sackers affirmed that the company’s growth trajectory has been noteworthy, revealing a 7% increase in the first quarter, followed by steady 6% growth in the subsequent quarters. These figures, he noted, reflect strong market approval and a robust approach to business amidst uncertainties.

Kumar emphasized the importance of understanding the factors driving Qiagen’s above-average performance, as he noted the company’s historical strength in serving sectors such as the National Institutes of Health (NIH) and academic research. This background sets a strong foundation for Qiagen to leverage existing relationships and capitalize on new opportunities, despite external challenges.

The conversation also touched on the broader economic landscape and how it affects life sciences companies. As industries adapt to fluctuations in market demands, maintaining a focus on innovation and collaboration with research institutions is increasingly critical for sustained success.

Sackers’ comments underscored Qiagen’s commitment to strategic growth and innovation, suggesting that the company will continue to prioritize customer relationships and the development of advanced technological solutions as it navigates future uncertainties.

The positive feedback from the conference participants indicates a high level of confidence in Qiagen’s leadership and strategic direction, paving the way for potential growth in various sectors. As the company moves forward, its performance will likely remain a key indicator of resilience and adaptability in the life sciences field.